Ten-year survival of patients with hepatocellular carcinoma after hepatectomy
Related Experiment Video
Updated: Jul 15, 2026
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Koji Hashimoto1, Yasuharu Ikeda, Daisuke Korenaga
1Department of Surgery, Fukuoka City Hospital, 13-1 Yoshizuka, Hakata-ku, Fukuoka 812-0046, Japan. hkoji1969@yahoo.co.jp
Background/Aims:
The characteristics in patients with hepatocellular carcinoma who survive more than 10 years after hepatectomy remain unclear.
Methodology:
Eighty-five cases of hepatocellular carcinoma were retrospectively identified as short-term survivors (S-group: <5 years, n=41), medium-term survivors (M-group: > or =5 and <10 years, n=25), and long-term survivors (L-group: > or =10 years, n=19) to examine the clinicopathologic factors for the 10-year survival after curative hepatectomy.
Results:
In the L-group, platelet count and albumin level were higher and total bilirubin level was lower than those in the S-group. In the S-group, the total bilirubin level was higher and vascular invasion was more frequent than those in the M-group. Multiple regression analysis revealed that only host-related factors such as age, albumin level, and total bilirubin level were selected as significant factors to determine the 10-year survival. However, no tumor-related factor was selected.
Conclusions:
The present study suggests that the important factor linked to the 10-year survival of hepatocellular carcinoma patients is the host-related factor, but not the tumor-related factor. Especially, younger age, higher albumin level, and lower total bilirubin level are quite important to determine the 10-year survival.
